Clinical Trials
52
Active:3
Completed:18
Trial Phases
5 Phases
Phase 1:2
Phase 2:3
Phase 3:1
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (45 trials with phase data)• Click on a phase to view related trials
Not Applicable
37 (82.2%)Phase 2
3 (6.7%)Phase 1
2 (4.4%)Phase 4
2 (4.4%)Phase 3
1 (2.2%)No trials found
News
World-First Immunotherapy Trial Aims to Reprogram Immune System in Type 1 Diabetes
Australian researchers at The University of Queensland have dosed the first five participants in a groundbreaking clinical trial of ASITI-201, an immunotherapy designed to rebalance immune response in Type 1 diabetes.